Table 1 Socio-demographic, reproductive and sexual characteristics by randomization group at enrolment
From: Papanicolaou smears and cervical inflammatory cytokine responses
Characteristic | Intervention: received a Pap Smear (n = 41) | Control: did not receive a Pap Smear (n = 39) | P-value |
|---|---|---|---|
Age [median years (IQR)] | 21.5 (20.0–23.0) | 21 (20.0–22.8) | 0.4 |
Vaginal intercourse during follow-up [n (%)] | 21 (51.2) | 17 (43.6) | 0.5 |
Number of acts of vaginal intercourse [median years (IQR)] | 3 (1.5–4.5) | 1 (1–2) | 0.1 |
Abnormal Pap smear during study [n (%)] | 4 (9.8) | 4 (10.3) | 0.9 |
Ever pregnant [n (%)] | 3 (7.1) | 8 (20.0) | 0.1 |
Number of live births among ever pregnant [n (%)] | 0 (0.0) | 2 (25.0) | 0.2 |
Ever Pap smear [n (%)] | 13 (30.9) | 8 (20.0) | 0.3 |
Number of Pap smears [median (IQR)] | 2 (1–2) | 1 (1–1.8) | 0.2 |
Currently using hormonal contraception [n (%)] | 19 (45.2) | 17 (42.5) | 0.8 |
Currently using [n(%)] | |||
Condom | 28 (66.7) | 32 (80.0) | 0.2 |
Combined oral contraceptive pills | 13 (30.9) | 8 (20.0) | 0.3 |
Injectable | 6 (14.6) | 9 (22.5) | 0.3 |
Ever vaginal discharge of concern [n (%)] | 14 (33.3) | 19 (47.5) | 0.2 |
Age first vaginal intercourse [median years (IQR)] | 18 (17–19) | 17 (17–18.8) | 0.4 |
Lifetime no. of sexual partners [median (IQR)] | 2 (1–4) | 2 (2–3) | 0.5 |
Ever condom use [n (%)] | 39 (92.8) | 38 (95.0) | 0.7 |
Always condom use [n (%)] | 17 (43.5) | 18 (47.4) | 0.7 |
Rarely condom use [n (%)] | 5 (12.8) | 5 (13.2) | 0.9 |
Use tampons when menstruating [n (%)] | 25 (59.9) | 26 (65.0) | 0.6 |